Trial Profile
CNTF Cell Implants For Glaucoma: A Phase I Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs NT 501 (Primary)
- Indications Glaucoma
- Focus Adverse reactions
- 29 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Nov 2014 New trial record